OKYO Pharma Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | +199,515.4% | – | – | -100.0% | +212,233.3% | – | – | +0.0% | -31.3% | +5.6% | |
| – | -100.0% | +199,899.3% | -99.7% | +199,936.9% | -100.0% | +100.0% | +2.9% | +0.0% | – | – | – | |
| – | – | +199,894.6% | -100.0% | +199,908.3% | -100.0% | – | – | +4,720,192.2% | 0.0% | -19.0% | +55.9% | |
| – | -100.0% | -31.5% | -100.0% | – | – | – | -100.0% | – | +0.0% | -99.7% | +151,800.0% | |
| – | -100.0% | – | – | – | – | – | – | – | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | +199,900.0% | -100.0% | +199,946.0% | -100.0% | +200,002.9% | -99.8% | +200,184.0% | 0.0% | +105.2% | +379.6% | |
| – | -100.1% | – | – | – | – | – | – | – | +0.0% | +363.6% | +290.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.